XML 39 R13.htm IDEA: XBRL DOCUMENT v2.4.0.8
STOCKHOLDERS' EQUITY
 3 Months Ended
Sep. 30, 2014
STOCKHOLDERS' EQUITY [Abstract]  
STOCKHOLDERS' EQUITY
NOTE 6: - STOCKHOLDERS' EQUITY
 
 
a.
From July 2014 through September 2014, a total of 949,210 warrants were exercised via “cashless” exercise, resulting in the issuance of 461,570 shares of common stock to investors of the Company.  In addition, 72,667 warrants were exercised for cash and resulted in the issuance of 72,667 shares of common stock to investors of the Company. The aggregate cash consideration received was $109.
 
 
b.
Following a shelf registration on Form S-3 filed and declared effective in October 2011, the Company entered in December 2012 into an At Market Issuance Sales Agreement (“ATM Agreement”) with an underwriter. On September 11, 2014, the Company notified the underwriter of the termination of the ATM Agreement.
 
 
c.
Options, warrants and restricted stock units to employees, directors and consultants:
 
 
1.
Options to employees and directors:
 
A summary of the Company's share option activity for options granted to employees and directors under the Plans is as follows:

 
Three months ended September 30, 2014 (Unaudited)
  
 
Number
    
Weighted Average Exercise Price
    
Weighted Average Remaining Contractual Terms (in years)
    
Aggregate Intrinsic Value Price
  
Options outstanding at beginning of period
     1,862,099     $ 3.73              
Options exercised
     (3,000 )   $ 0.62              
Options forfeited
     -                      
Options outstanding at end of the period
     1,859,099     $ 3.73       2.87     $ 929  
Options exercisable at the end of the period
     1,859,099     $ 3.73       2.87     $ 929  
Options vested
     1,859,099     $ 3.73       2.87     $ 929  
 
Intrinsic value of exercisable options (the difference between the Company's closing stock price on the last trading day in the period and the exercise price, multiplied by the number of in-the-money options) represents the amount that would have been received by the employees and directors option holders had all option holders exercised their options on September 30, 2014. This amount changes based on the fair market value of the Company's common stock.
 
 
 

 
2.
Options and warrants to non-employees:

A summary of the Company's activity related to options and warrants to consultants is as follows:

During the three month period ended September 30, 2014, there were no grants, exercised or forfeitures of options and warrants to non-employees consultants.
 
 
Three months ended September 30, 2014 (Unaudited)
  
 
Number
    
Weighted Average Exercise Price
    
Weighted Average Remaining Contractual Terms (in years)
    
Aggregate Intrinsic Value Price
  
Options and warrants outstanding at beginning of period
     252,000     $ 5.19              
Options and warrants outstanding at end of the period
     252,000     $ 5.19       3.71     $ 300  
                                 
Options and warrants exercisable at the end of the period
     252,000     $ 5.19       3.71     $ 300  
                                 
Options and warrants vested and expected to vest
     252,000     $ 5.19       3.71     $ 300  
 
Compensation expenses related to options and warrants granted to consultants were recorded as follows:
 
 
Three months ended September 30,
  
 
2014 (Unaudited)
    
2013 (Unaudited)
  
Research and development expenses
   $ 1     $ -  
General and administrative expenses
     -       2  
    $ 1     $ 2  

 
 
 
 
3.
Restricted stock units to employees and directors:
 
During the three month period ended September 30, 2014, the Company granted restricted stock units to several of the Company's employees and directors.
 
The following table summarizes the activities for unvested restricted stock units granted to employees and directors for the three months ended September 30, 2014 (Unaudited):
 

   
Number
  
Unvested at the beginning of period
     1,589,432  
Granted
     24,499  
Forfeited
     (8,725 )
Vested
     (439,078 )
Unvested at the end of the period
     1,166,128  
Expected to vest after  September 30, 2014
     1,141,828  
 
Compensation expenses related to restricted stock units granted to employees and directors were recorded as follows:
 
 
Three months ended September 30,
  
 
2014 (Unaudited)
    
2013 (Unaudited)
  
Research and development expenses
   $ 333     $ 126  
General and administrative expenses
     702       1,048  
    $ 1,035     $ 1,174  
 
 
Unamortized compensation expenses related to restricted stock units granted to employees and directors to be recognized of an average time of approximately 2 years is $1,499.
 
 
 
 
 
4.
Restricted stock units to consultants:
 
During the three month period ended September 30, 2014, the Company granted restricted stock units to several consultants and service providers.
 
The following table summarizes the activities for unvested restricted stock units granted to consultants for the three months ended September 30, 2014:
 
   
Number
  
Unvested at the beginning of period
     15,250  
Granted
     5,000  
Forfeited
     -  
Vested
     (7,875 )
Unvested at the end of the period
     12,375  
Expected to vest after September 30, 2014
     12,375  
 
Compensation expenses related to restricted stock units granted to consultants were recorded as follows:
 
 
Three months ended September 30,
  
 
2014 (Unaudited)
    
2013 (Unaudited)
  
Research and development expenses
   $ 20     $ -  
General and administrative expenses
     4       -  
    $ 24     $ -